Jeffrey Sparks MD MMSc
banner
jeffsparks.bsky.social
Jeffrey Sparks MD MMSc
@jeffsparks.bsky.social
Rheumatologist | Associate Professor of Medicine | @BrighamWomens | @harvardmed | Investigating rheumatoid arthritis susceptibility, RA-ILD, and outcomes | ⚡️⚡️
Reposted by Jeffrey Sparks MD MMSc
Abs 2662 McDermott @jeffsparks.bsky.social

🔎 Target trial emulation to address the Q of whether guidelines like ACR and CHEST are appropriate for conditionally recommending RTX over other biologics for RA-ILD?

📊 Data source: Medicare
👨‍👨‍👦 Study pop: RA ILD

#ACR25
October 28, 2025 at 11:02 PM
thanks to funder (NIH/NIAMS), participants, and staff across 5 sites in the US to make SAIL-RA possible!
October 22, 2025 at 11:21 PM
We also performed validation of proposed ILD screening strategies in early RA and displayed good performance using simple clinical factors such as age, sex, disease activity, and RF/CCP.
October 22, 2025 at 11:21 PM
Reposted by Jeffrey Sparks MD MMSc
Alu expression in dermatomyositis muscle tissue
doi.org/10.1002/art....

Characterizing a cohort of patients with SpA spectrum disorders initially presenting as PMR
doi.org/10.1002/art....

Patients with RA-associated lung disease at increased risk of serious infection
doi.org/10.1002/art....

August 2, 2025 at 1:01 PM
and NIAMS!
May 31, 2025 at 10:42 AM
Reposted by Jeffrey Sparks MD MMSc
Thank you to the #NephMadness Selection Committee members who helped us develop the teams in each region:

- @jordybc.bsky.social
- Mehmet Sever
- @thenestor.bsky.social
- @jeffsparks.bsky.social
- Mariana Murea
- @lawdishu.bsky.social
- Swee-Ling Levea
- Babak Orandi
- Susan Samuel
April 17, 2025 at 3:23 PM